This compound is an Fmoc-protected amino acid building block specifically featuring a tert-butoxy-protected hydroxyproline residue. It is primarily used in solid-phase peptide synthesis as a protected precursor for incorporating modified proline derivatives into synthetic peptides.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 122996-47-8
N-Fmoc-(2S,5S)-5-tert-butoxypipecolicacid
Pharmaceutical intermediate
(2S,5R)-5-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate for peptide synthesis
(2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,4S)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
Pharmaceutical intermediate
(S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(7-FLUORO-1H-INDOL-3-YL)PROPANOIC ACID
Fmoc-protected amino acid building block
Fmoc-(Me)Gly(Pentynyl)-OH
Fmoc-protected amino acid building block
Sphingosine
sphingolipid base component
Thiomorpholine
research compound
(2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxylic acid
WPBXBYOKQUEIDW-VFNWGFHPSA-N
CC(C)(C)O[C@@H]1C[C@H](N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O